REG - Thruvision Group PLC - Notice of Interim Results

ThruvisionAnnouncement

10/11/2020 07:00

RNS Number : 7376E
  
Thruvision Group PLC
  
10 November 2020
  
 

 
RNS
10 November 2020
Thruvision Group plc
 
("Thruvision")
 
Notice of Interim Results
 
 
Thruvision (AIM: THRU) the specialist provider of people-screening technology to the international security market, will announce its interim results for the period ended 30 September 2020 on Monday 23 November 2020.
 
 
For further information please contact:
 
Thruvision Group plc                                                                     +44 (0)1235 436180
Tom Black, Executive Chairman
Colin Evans, Chief Executive
 
Investec Bank plc                                                                             +44 (0)20 7597 5970
James Rudd / Sebastian Lawrence / Patrick Robb
 
FTI Consulting LLP                                                                           +44 (0)20 3727 1000
Matt Dixon / Shamma Kelly
 
About Thruvision
Thruvision is the leading provider of safe distance, people security screening technology. Using patented passive terahertz technology, Thruvision is uniquely capable of detecting metallic and non-metallic threats including weapons, explosives and contraband items that are hidden under clothing, at distances between 3m and 10m. Addressing the growing need for safe, fast and effective security, Thruvision completely removes the need for physical "pat-downs" and has been vetted and approved by the US Transportation Security Administration for surface transportation. Operationally deployed in 20 countries around the world, Thruvision is used for aviation and transportation security, retail supply chain loss prevention, facilities and public area protection and customs and border control. The company has offices near Oxford, and in Washington DC.
 
www.thruvision.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
NORDKLFBBFLXFBQ